Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-13

Clinical Trial Update: Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550 [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the effect of atorvastatin on cholesterol in patients with rheumatoid arthritis who are taking tofacitinib (CP-690,550); results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tofacitinib (CP-690,550) (tofacitinib)
  • atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2012-12-13